Tenax Therapeutics (TENX) Short Interest Ratio & Short Volume → The ONE AI Stock to own now. (It’s not Nvidia.) (From Weiss Ratings) (Ad) Free TENX Stock Alerts $3.63 +0.08 (+2.25%) (As of 09:35 AM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestSocial Media Tenax Therapeutics Short Interest DataCurrent Short Volume35,200 sharesPrevious Short Volume49,000 sharesChange Vs. Previous Month-28.16%Dollar Volume Sold Short$126,896.00Short Interest Ratio / Days to Cover0.1Last Record DateApril 15, 2024Outstanding Shares1,958,000 sharesFloat Size1,870,000 sharesShort Percent of Float1.88%Today's Trading Volume2,371 sharesAverage Trading Volume254,927 sharesToday's Volume Vs. Average1% Short Selling Tenax Therapeutics ? Sign up to receive the latest short interest report for Tenax Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatTENX Short Interest Over TimeTENX Days to Cover Over TimeTENX Percentage of Float Shorted Over Time Ad Stansberry ResearchThings Are Not Normal in America – Here’s What to DoGet Out of the Dollar Before May 15 A Wall Street legend and our friend has just warned 896,000 Americans to prepare for May 15.This could be your solution. Tenax Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/202435,200 shares $126,896.00 -28.2%1.9%0.1 $3.61 3/31/202449,000 shares $207,760.00 +33.5%2.6%0.1 $4.24 3/15/202436,700 shares $137,625.00 -49.4%2.2%0.1 $3.75 2/29/202472,500 shares $332,775.00 +56.3%4.3%0.2 $4.59 2/15/202446,400 shares $194,416.00 +30.7%2.8%0.2 $4.19 1/31/202435,500 shares $452,625.00 +153.6%12.2%0.1 $12.75 Get the Latest News and Ratings for TENX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Tenax Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/15/202414,000 shares $199,360.00 +833.3%4.8%0.2 $14.24 12/31/20231,500 shares $32,952.00 -99.0%0.5%0 $21.97 12/15/2023155,600 shares $40,362.64 -76.1%N/A0 $0.26 11/30/2023651,100 shares $227,233.90 -78.1%N/A0.1 $0.35 11/15/20232,970,000 shares $1.48 million +16,308.8%N/A0.4 $0.50 10/31/202318,100 shares $3,357.55 +43.7%N/A0 $0.19 10/15/202312,600 shares $3,969.00 -84.9%N/A0 $0.32 9/30/202383,200 shares $24,876.80 +263.3%N/A0.2 $0.30 9/15/202322,900 shares $7,786.00 +114.0%N/A0 $0.34 8/31/202310,700 shares $3,743.93 -69.4%N/A0 $0.35 8/15/202335,000 shares $10,493.00 +1.2%N/A0 $0.30 7/31/202334,600 shares $10,902.46 -73.7%N/A0 $0.32 7/15/2023131,400 shares $40,339.80 -74.4%N/A0.2 $0.31 6/30/2023513,000 shares $153,900.00 -10.3%N/A0.7 $0.30 6/15/2023572,000 shares $165,880.00 +526.5%N/A0.6 $0.29 5/31/202391,300 shares $33,105.38 -48.6%1.1%0 $0.36 5/15/2023177,600 shares $58,963.20 -1.3%2.0%0.1 $0.33 4/30/2023179,900 shares $58,107.70 -9.5%2.1%0.1 $0.32 4/15/2023198,800 shares $72,959.60 -13.6%2.3%0 $0.37 3/31/2023230,000 shares $106,950.00 -89.4%2.6%0.1 $0.47 3/15/20232,160,000 shares $1.23 million +387.7%24.8%0.6 $0.57 2/28/2023442,900 shares $301,172.00 +21.9%6.3%0.2 $0.68 2/15/2023363,400 shares $339,742.66 +306.9%5.2%0.4 $0.93 1/31/202389,300 shares $189,316.00 -12.7%4.8%0.1 $2.12 1/15/2023102,300 shares $241,428.00 +209.1%5.5%0.3 $2.36 12/30/202233,100 shares $3,687.31 -94.4%1.8%0.1 $0.11 12/15/2022593,200 shares $78,243.08 -57.9%N/A0.1 $0.13 11/30/20221,410,000 shares $208,680.00 +260.4%N/A0.3 $0.15 11/15/2022391,200 shares $52,851.12 +96.3%N/A0.1 $0.14 10/31/2022199,300 shares $26,287.67 -4.4%17.2%0.1 $0.13 10/15/2022208,500 shares $30,962.25 +43.4%18.0%0.4 $0.15 9/30/2022145,400 shares $24,718.00 +146.0%12.5%0.3 $0.17 9/15/202259,100 shares $15,366.00 -10.3%5.1%0.1 $0.26 8/31/202265,900 shares $15,750.10 +1,120.4%5.7%0.3 $0.24The ONE AI Stock to own now. (It’s not Nvidia.) (Ad)Don’t panic — you haven’t missed the boat on AI. In fact, it has barely launched. Sure, the early stages of this boom were big … But I believe the real wealth in AI has yet to be made …Click here to see the presentation now. TENX Short Interest - Frequently Asked Questions What is Tenax Therapeutics' current short interest? Short interest is the volume of Tenax Therapeutics shares that have been sold short but have not yet been closed out or covered. As of April 15th, investors have sold 35,200 shares of TENX short. 1.88% of Tenax Therapeutics' shares are currently sold short. Learn More on Tenax Therapeutics' current short interest. What is a good short interest percentage for Tenax Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.88% of Tenax Therapeutics' floating shares are currently sold short. Is Tenax Therapeutics' short interest increasing or decreasing? Tenax Therapeutics saw a decline in short interest in the month of April. As of April 15th, there was short interest totaling 35,200 shares, a decline of 28.2% from the previous total of 49,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Tenax Therapeutics' float size? Tenax Therapeutics currently has issued a total of 1,958,000 shares. Some of Tenax Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Tenax Therapeutics currently has a public float of 1,870,000 shares. How does Tenax Therapeutics' short interest compare to its competitors? 1.88% of Tenax Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Tenax Therapeutics: Pulmatrix, Inc. (0.32%), Shuttle Pharmaceuticals Holdings, Inc. (0.77%), TransCode Therapeutics, Inc. (0.28%), Processa Pharmaceuticals, Inc. (8.28%), ASLAN Pharmaceuticals Limited (1.47%), Ainos, Inc. (2.84%), Kineta, Inc. (1.23%), Enveric Biosciences, Inc. (1.40%), Pasithea Therapeutics Corp. (1.34%), Hepion Pharmaceuticals, Inc. (1.19%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Tenax Therapeutics stock? Short selling TENX is an investing strategy that aims to generate trading profit from Tenax Therapeutics as its price is falling. TENX shares are trading up $0.07 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Tenax Therapeutics? A short squeeze for Tenax Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of TENX, which in turn drives the price of the stock up even further. How often is Tenax Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TENX, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: PULM Short Interest Data SHPH Short Interest Data RNAZ Short Interest Data PCSA Short Interest Data ASLN Short Interest Data AIMD Short Interest Data KA Short Interest Data ENVB Short Interest Data KTTA Short Interest Data HEPA Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:TENX) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaThis 1 Biotech Stock has been shocking the marketsHuge AlertsThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldHe Is Giving Away BitcoinCrypto Swap ProfitsDems have chosen Biden replacement?Paradigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmithRich Dad Poor Dad Author Shocks Millions With 2024 Crash WarningAmerican Hartford Gold GroupUrgent Nvidia WarningAltimetry